-
The ACTIV-6 Study | Activ-6 Study
What is the ACTIV-6 Study?
ACTIV-6 is a national study to find out whether certain medications approved by the U.S. Food & Drug Administration (FDA) can help people with mild-to-moderate COVID-19 feel...
-
Study Results | Activ-6 Study
Study Results
Although the ACTIV-6 study is ongoing, we believe it is important to share the results for individual medication arms as soon as they are available. These results do not impact participa...
-
ACTIV-6 Resources | Activ-6 Study
Privacy Statement
WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible ...
-
Welcome to the ACTIV-6 Study | Activ-6 Study
You are 30 years old or older.
Tested positive for COVID-19 within the past 10 days.
Have at least 2 COVID-19 symptoms for 7 days or less. Symptoms include fatigue, difficulty breathing, fever, cough,...
-
For Participants | Activ-6 Study
Share your ACTIV-6 Story
In addition to helping researchers discover accessible and affordable medicines for people with COVID-19, you now have an opportunity to share why you enrolled in ACTIV-6. You...
-
Latest News | Activ-6 Study
Sept. 8, 2021
Interview with Adrian Hernandez, MD, MHS, Administrative Principal Investigator for ACTIV-6 and Executive Director, Duke Clinical Research Institute
Aug. 10, 2021
Adrian Hernandez, MD,...